Inter Pharma Share Price

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 02/07/2026			5-day change	1st Jan Change
4.440 ^THB	-0.89%		+2.30%	-3.48%

05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
02/07/26	THB 4.440	-0.89%	133,460
01/07/26	THB 4.480	+0.45%	478,392
30/06/26	THB 4.460	-0.45%	65,956
29/06/26	THB 4.480	+2.75%	527,961
26/06/26	THB 4.360	-0.91%	280,117

End-of-day quote Thailand S.E.

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Cap	2.69B 81M 70.78M 64.99M 60.61M 115M 7.71B 117M 783M 303M 3.78B 304M 298M 13.03B	P/E 2024	52.3x	P/E 2025	22.8x
Enterprise Value	2.81B 84.59M 73.92M 67.88M 63.3M 120M 8.05B 122M 817M 317M 3.95B 318M 311M 13.61B	EV / Sales 2024	1.13x	EV / Sales 2025	1.31x
Free-Float	-	Yield 2024 *	-	Yield 2025	1.59%

05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-01	Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026	CI
11-11	Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients.	CI
11-11	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
16/04/25	Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal	MT
16/04/25	Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited	CI
01/04/25	Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation	CI
25/02/25	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/02/25	Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024	CI
13/11/24	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

17/08/22	Inter Pharma : New shares of IP to be traded on August 18, 2022	PU
10/08/22	Inter Pharma Public : Notification on Change of Directors and Authorization of Directors	PU
10/08/22	Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1 (Edited)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1	PU

1 day	-0.89%
1 week	+2.30%
Current month	-0.45%
1 month	+3.74%
3 months	+7.77%
6 months	-3.48%
Current year	-3.48%

1 week	4.32	4.5
1 month	4.28	4.56
Current year	3.68	4.62
1 year	3.14	4.7
3 years	2.02	7.88
5 years	2.02	14.95
10 years	1.62	15.14

Inter Pharma Share Price

Stocks

IP

TH9474010005

Pharmaceuticals

Valuation: Inter Pharma

Chart: Inter Pharma

Latest news : Inter Pharma

Press Releases: Inter Pharma

Quotes and Performance

Course Extremes

Managers and Directors: Inter Pharma

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

Manager	Title	Age	Since
Trinnawat Thanitnithiphan CEO	Chief Executive Officer	56	31/01/2014
Chatkaew Krudkosol DFI	Director of Finance/CFO	56	22/06/2023
Chompunuch Meevang CMP	Compliance Officer	54	-

Director	Title	Age	Since
Napaporn Dechakarat BRD	Director/Board Member	51	13/06/2017
Sansanee Chaiyaroj BRD	Director/Board Member	64	31/07/2020
Trinnawat Thanitnithiphan BRD	Director/Board Member	56	31/01/2014

Date	Insider	Type	Main position	Quantity	% Market Cap.
05-20	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	60,000	0.0099%
05-20	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	60,000	0.0099%
05-19	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	22,600	0.0037%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTER PHARMA	-0.89%	+2.30%	+43.23%	-36.15%	81.43M
ELI LILLY AND COMPANY	+1.86%	+7.65%	+55.77%	+158.84%	1,063B
JOHNSON & JOHNSON	+3.57%	+7.42%	+69.09%	+58.92%	611B
ABBVIE INC.	+3.99%	+7.37%	+36.87%	+93.77%	444B
ROCHE HOLDING AG	-1.20%	-0.96%	+26.12%	+20.22%	324B
ASTRAZENECA PLC	+4.94%	+4.51%	+39.76%	+28.93%	285B
NOVARTIS AG	+2.42%	+2.96%	+30.77%	+42.24%	283B
NOVO NORDISK A/S	+2.47%	+6.56%	-24.26%	-39.60%	219B
AMGEN INC.	+3.55%	+6.05%	+26.04%	+68.52%	195B
GILEAD SCIENCES, INC.	+4.21%	+6.00%	+17.72%	+70.33%	156B
Average	+2.02%	+2.73%	+32.11%	+46.60%	358.08B
Weighted average by Cap.	+1.85%	+4.16%	+41.60%	+80.68%

	2024	2025
Net sales	1.91B 57.62M 50.35M 46.23M 43.11M 81.74M 5.49B 83.11M 557M 216M 2.69B 216M 212M 9.27B	2.21B 66.72M 58.3M 53.54M 49.93M 94.65M 6.35B 96.25M 645M 250M 3.12B 251M 245M 10.74B
Net income	37.28M 1.12M 982K 901K 841K 1.59M 107M 1.62M 10.85M 4.21M 52.46M 4.22M 4.13M 181M	122M 3.69M 3.22M 2.96M 2.76M 5.23M 351M 5.32M 35.63M 13.81M 172M 13.85M 13.55M 593M
Net Debt	209M 6.3M 5.5M 5.05M 4.71M 8.93M 599M 9.08M 60.82M 23.57M 294M 23.64M 23.13M 1.01B	119M 3.59M 3.14M 2.88M 2.69M 5.1M 342M 5.19M 34.73M 13.46M 168M 13.5M 13.2M 578M